research

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer

Authors
    Publication date
    2016
    Publisher
    Springer
    Doi

      Abstract

      Abstract is not available.

        Similar works

        Full text

        thumbnail-image

        Springer - Publisher Connector

        redirect
        Last time updated on 29/04/2017

        This paper was published in Springer - Publisher Connector.

        Having an issue?

        Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.